β thalassemia major in Argentina

Medicina

Volumn 62, Issue 2, 2002, Pages 124-134

  Torres, Aurora Feliu ^a   Bonduel, Mariana ^a   Sciuccati, Gabriela ^a   Del Pozo, Ana ^a   Roldán, Ariel ^a   Ciaccio, Marta ^a   Orazi, Virginia ^a   Fano, Virginia ^a   Ozuna, Blanca ^a   Lejarraga, Horacio ^a   Muriel, Federico Sackmann ^a  

^a HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

Author keywords

thalassemia major; Argentina; Clinical management

Indexed keywords

ALLOANTIBODY; ALPHA GLOBIN; BETA GLOBIN; DEFEROXAMINE; GROWTH HORMONE; SOMATOMEDIN C;

ADRENAL INSUFFICIENCY; ALLOGRAFT; ARGENTINA; ARTICLE; BLEEDING; BLOOD TRANSFUSION REACTION; BODY GROWTH; BODY HEIGHT; CAUSE OF DEATH; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ECONOMIC ASPECT; FAMILY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GLUCOSE INTOLERANCE; GROWTH RATE; HEART DISEASE; HEART FAILURE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HETEROZYGOTE; HOSPITAL ADMISSION; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; HYPOTHYROIDISM; IMMIGRANT; INFANT; INFECTION; ITALY; MALE; MORTALITY; OUTCOMES RESEARCH; PREPUBERTY; PRESCHOOL CHILD; SEPSIS; SEX DIFFERENCE; SIBLING; THALASSEMIA MAJOR; X RAY; BETA THALASSEMIA; CHILD; FOLLOW UP; GENETIC SCREENING; GENETICS; MUTATION; RETROSPECTIVE STUDY;

ARGENTINA; BETA-THALASSEMIA; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; GENETIC SCREENING; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; MALE; MUTATION; RETROSPECTIVE STUDIES;

EID: 2242449651     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. The Thalassemias
2. A series of cases of splenomegaly in children with anemia and peculiar bone changes
3. Treatment of Cooley's Anemia
4. Benefits and Complications of regular Blood Transfusion in Patients with Beta-Thalassemia major
5. Reassessment of the use of deferoxamine B in iron overload
6. Continuous subcutaneous administration of deferoxamine in patients with iron overload
7. Bone Marrow Transplantation in patients with Thalassemia
8. Recommendations of a system for identifying abnormal hemoglobins
9. 2
10. Estimation of small percentages of fetal hemoglobin
11. A simple method for the detection of unstable hemoglobins
12. Molecular Characterization of β-Thalassemia Genes in an Argentine Population
13. Rapid Detection of Deletions Causing db Thalassemia and Hereditary Persistence of Fetal Hemoglobin by Enzymatic Amplification
14. Criterios de diagnóstico y tratamiento. Comité de crecimiento y desarrollo
15. Normas y Técnicas antropométricas Criterios de atención
16. Estándares para la evaluación del crecimiento Criterios de atención
17. Estándares de peso y estatura para niñas y niños argentinos desde el nacimiento hasta la madurez
18. Physical development
19. Determination of the Spectrum of β-Thalassemia genes in Spain by Use of Dot-Blot Analysis of Amplified β-globin DNA
20. Bone Marrow Transplantation in Thalassaemia: The experience of Pesaro
21. New approaches to the transfusion management of thalassemia
22. The management of patients with Cooley's anemia: Transfusions and Splenectomy
23. Long-term Chelation Therapy in Thalassemia Major: Effect on Liver Iron Concentration, Liver Histology, and Clinical Progress
24. Reassessment of the use of desferrioxamine B in iron overload
25. Continuous subcutaneous administration of desferoxamine in patients with iron overload
26. Combined therapy with deferiprone and desferrioxamine
27. Desferrioxamine-chelatable iron, a component of serum non-transferrin-bound iron, used for assessing chelation therapy
28. Phlebotomy to reduce iron overload in patients cures of thalassemia by bone marrow transplantation
29. Desferoxamine therapy accelerates clearence of iron deposits after bone marrow transplantation
30. Growth failure and bone lesions due to desferrioxamine in thalassaemic patients
31. Short Stature and Body Proportion in Thalassaemia
32. High Incidence of Osteoporosis in Thalassaemia Major
33. Bone Density and Metabolism in Thalassaemia
34. Genetic and Acquired Predisposing Factors and Treatment of Osteoporosis in Thalassemia
35. Long Term Follow up of Skeletal Dysplasia in Thalassaemia Major
36. Growth Hormone Secretion and Bone Histomorphometric Study in Thalassaemic Patients with Acquired Skeletal Dysplasia Secondary to Desferrioxamine
37. Acute Metabolic Effects of Human Growth Hormone on 15 N-Nitrogen Balance in Patients with Thalassaemia as Compared to Patients with Other Types of Short Stature
38. In-vitro response of erythroid progenitors from children with thalassaemia major to human growth hormone and insulin-like growth factor I
39. Iron chelation therapy and the treatment of thalassaemia